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1. Introduction
   Salmonella enterica, which is a group of Gram-negative bacterial 
pathogens capable of infecting humans and animals, cause significant 
morbidity and mortality worldwide[1]. Certain serotypes adapted to 
human, such as Salmonella typhi (S. typhi) and Salmonella paratyphi 
(S. paratyphi), usually cause severe diseases in humans, such as enteric 
fevers (typhoid and paratyphoid fevers). In most endemic areas like 
Africa, Asia, and Latin America[2], approximately 90% of enteric fever 
is typhoid. This disease is an important global health problem with an 
estimated 16 million cases and 600 000 deaths each year[3]. Typhoid is 
transmitted by the faecal-oral route via contaminated food and water 
and is therefore common where sanitary conditions are inadequate 
and access to clean water is limited. The use of antibiotics is a major 
strategy for the fight against these bacteria, and antimicrobial agents 
are commonly used therapeutically and prophylactically in human and 
animal salmonellosis. However, conventional antityphoid drugs are 
becoming more and more unavailable to the common man in Africa 
due to increased cost[4]. Moreover, the typhoid causative organism, S. 
typhi, has rapidly gained resistance to the previously efficacious drugs 
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Objective: To investigate the in vivo anti-salmonella activity and the safety of aqueous extract of 
Euphorbia prostratra (E. prostratra), a plant commonly used in Cameroon by traditional healers.
Methods: A Salmonella typhimurium-infected rat model was used for the study. The 
physiological, biochemical and histopathological markers of possible side effects of this extract 
were studied using standard methods. 
Results: The extract had a significant effect on the number of viable Salmonella typhimurium 
recovered from faeces, and could stop salmonellosis after 8 and 10 days of treatment for 
male and female rats, respectively, with non-toxic doses. However, the biochemical and 
histopathological analyses revealed that at relatively high doses (≥ 73.48 mg/kg for female 
and ≥ 122.71 mg/kg for male) the extract could induce liver damage, as illustrated by a rise of 
serum transaminases’ levels and significant inflammation of the parenchyma and portal vein. 
Side effects were also observed on the kidneys, as shown by both serum and urinary creatinine, 
and urinary proteins. 
Conclusions: The overall results indicate that the aqueous extract of E. prostrata has the 
potential to provide an effective treatment for salmonellosis, including typhoid fever. However, 
it is necessary to extrapolate these results in large animals, in further studies.
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like ciprofloxacin[5]. Hence, there is a need for new antityphoid 
agents.
   Studies have shown that the pathogenicity and virulence of 
Salmonella is host specific[6]. S. typhi induces a systemic infection 
in humans but not in mice or rats, while Salmonella typhimurium 
(S. typhimurium) induces a systemic infection in mice and rats 
(similar to that induced by S. typhi in humans) and just a localized 
gastroenteritis in humans. Thus, salmonellosis induced by S. 
typhimurium in rats has many similarities to the typhoid fever 
in human, with the primary site of colonization being ileum in 
both species[7]. So S. typhimurium-infected rats or mice have 
been extensively used as models for the understanding of the 
pathophysiology of typhoid fever[6,8]. 
   Recently, there has been considerable interest in the use of 
plant materials as an alternative method of controlling pathogenic 
microorganisms[9], and many compounds from plants have been 
shown to be effective against resistant pathogenic bacteria[10]. 
According to WHO[11], medicinal plants are the best sources to 
obtain a variety of new herbal drugs. About 80% of individuals from 
developing countries use traditional medicine, which has substances 
derived from medicinal plants[11]. Therefore, such plants should 
be investigated to better understand their properties, safety and 
efficacy[12].
   Euphorbia prostrata (E. prostrata) is an annual herb, which belongs 
to family Euphorbiaceae and is abundantly found in India and Africa. It 
has been traditionally used in several digestive system disorders[13,14]. 
In Burkina Faso, the leaves are used as a remedy against the bites of 
venomous insects (wasps, scorpions, etc.). In Togo, this plant is used 
to fight against infertility and menstrual pain[15] and in the western 
rural parts of Cameroon, the whole plant of E. prostrata is very often 
used for the treatment of dysentery and typhoid fever. The in vitro 
antimicrobial activity of E. prostrata extracts against S. typhi, S. 
paratyphi A, S. paratyphi B and S. typhimurium has been demonstrated 
in our previous work[16]. It was also shown that the aqueous extract 
of E. prostrata could be considered as practically non-toxic, since the 
LD50 values of the extract were 23.2 g/kg and 26.4 g/kg for female and 
male mice, respectively[16]; i.e. the LD50 values were greater than 5 g/
kg, as stated by the Hodge and Sterner criteria[17]. 
   In order to evaluate the therapeutic potentials of E. prostrata for 
the treatment of salmonellosis (e.g. typhoid fever, gastroenteritis), we 
investigated the in vivo anti-salmonella activity of the aqueous extract 
against S. typhimurium.  The safety of this extract was also evaluated 
through subacute toxicological study.
2.  Materials and methods
2.1. Plant material 
   The whole plants of E. prostrata Ait were collected from Dschang 
(West region of Cameroon) in April 2010, and identified by the 
Cameroon National Herbarium (Yaoundé), where a voucher specimen 
was deposited (Ref N° 33585/HNC).
2.2. Test bacterium and culture medium
   S. typhimurium was used in this study and was provided by the 
Centre Pasteur, Yaoundé, Cameroon. Bacterial strain was maintained 
on agar slant at 4 ºC and sub-cultured on a fresh appropriate agar plate 
24 h prior to antimicrobial test.
   Salmonella-Shigella agar was used for the activation of Salmonella, 
and during in vivo assays in rats for bacterial counts and identification.
2.3. Experimental animals
   Wistar Albino rats (aged 7-8 weeks, weighing 170-210 g) of either 
sex were used in the study. They were bred at the animal house of 
Department of Biochemistry, University of Dschang in the ambient 
environmental conditions [(23 ± 2) ºC].
2.4. Chemicals for antimicrobial assay
   Ciprofloxacin and cyclophosphamid were used as reference antibiotic 
and immunosuppressor, respectively. 
2.5. Preparation of plant extract
   The whole plant of E. prostrata was collected and air-dried at room 
temperature and then pulverised. The extraction (infusion) was done 
according to traditional healer indications. Thus 97.20 g of the powder 
were soaked for 15 min in 2 L of boiled distilled water. The preparation 
was filtered using Whatman No. 1 filter paper. The filtrate was then 
concentrated by allowing it to stand in an oven (Memmert) set at 45 ºC.
2.6. In vivo assay using rats
   Male and female Wistar Albino rats were used for this study. 
Each sex was divided into 7 groups of 5 animals each (i.e. M0, 
M1, M2, M3, M4, M5, and M6 for males; F0, F1, F2, F3, F4, F5, and 
F6 for females). The rats were acclimatized [room temperature 
(23 ± 2) ºC, and a 12 h photoperiod] in cages (1 rat/cage) 
for one week before the commencement of the experiment. 
Salmonellosis was induced using the method proposed by Pan, 
et al[7], with modification. Briefly, rats were immunosuppressed 
by intraperitoneal injection with cyclophosphamid as described 
by Abhishek et al.[18] to facilitate the infection. At the third days 
of immunosuppression, the rats were fasted overnight and given, 
by gavage, 1 mL of saline solution (0.9% NaCl) containing 1.5 
× 108 CFU of Salmonella typhimurium, except animals of groups 
M0 and F0 (which were neither infected nor treated, and used as 
neutral control; they received distilled water). Animals of groups 
M1 and F1 (which were infected, but not treated) received distilled 
water during the treatment period, hence were used as negative 
control groups; and those of M6 and F6 received ciprofloxacin, and 
thus were used as positive control groups. To verify that infection 
has occurred, the bacterial load of the faeces of the animals was 
determined one day before infection and during four days following 
the infection: a steady increase in the bacterial load during the four 
days indicated the establishment of the infection. Graded doses (i.e. 
26.34, 44.00, 73.48, 122.71 mg/kg) of the aqueous extract of E. 
prostrata were administered to rats in groups M2 and F2, M3 and F3, 
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M4 and F4, and M5 and F5, respectively, by gastric intubation for 14 
consecutive days. These doses were chosen based on the traditional 
healer indications (i.e. 44 mg/kg body weight) and the minimum 
inhibitory concentration (MIC) result against S. typhimurium obtain 
in the previous work[16] (i.e. 26.34, 73.48, and 122.71 mg/kg body 
weight). The animals were maintained at room temperature [(23 
± 2) ºC] with a 12 h light-dark cycle and standard animal feed 
and water were provided ad libitum. After administration of the 
bacterial suspension (inoculum), faecal samples were then collected 
every day and the numbers of the bacteria per gram of faeces 
were determined. In fact, faeces collected were dissolved in saline 
distilled water (0.9% NaCl) at the proportion of 1 g for 2 mL of 
suspension. Aliquots (100 μL) of faecal suspensions were serially 
diluted in saline distilled water (0.9% NaCl) and then plated on 
duplicate Salmonella-Shigella agar plates, which were subsequently 
incubated overnight at 37 ºC. Typical colonies were then identified 
and counted on the plates. At the end of the treatment period, the 
biochemical, haematological and histological markers of possible 
side effects were evaluated in rats using standard methods and kits.
2.7. Collection of blood and preparation of serum sample
   This was done according to the method used by Gatsing et al[19]. 
At the end of the treatment period, rats were anaesthetized using 
chloroform vapour prior to dissection. Blood samples were collected 
by cardiac puncture into two different tubes, one containing 
anticoagulant [ethylene diamine tetraacetic acid (EDTA)] and the 
other without anticoagulant. The blood in the tube with EDTA was 
used for the determination of haematological parameters, whereas 
that in the tube without EDTA was used for the preparation of serum 
samples. For serum preparation, the blood was allowed to clot by 
standing at room temperature for one hour and then refrigerated for 
another 1 h. The resultant liquid part was centrifuged at 1 058 r/min 
for 10 min, and then the clear serum (supernatant) was isolated and 
stored at -30 ºC until required for analysis.
2.8. Relative organ weight and preparation of homogenates 
   After taking the blood, the abdominal cavity of each animal 
was opened and organs, namely the heart, liver, lungs, spleen 
and kidneys, were quickly removed, cleaned with ice-cold saline, 
weighed and stored at −80 ºC. The relative organ weight (organ 
to body weight ratio) of each animal was then calculated. The 
homogenates of various organs were prepared at 15% (15 g organ 
per 100 mL of 0.9% NaCl) as described by Gatsing et al[19]. This 
was done by grinding 500 mg of each organ in a mortar containing 
3.34 mL saline distilled water (0.9% NaCl), placed on a block of ice. 
The homogenates were centrifuged at 1 058 r/min for 15 min and the 
supernatants were then used for protein assays. 
2.9. Haematological assays 
   White blood cell (WBC) count, red blood cell (RBC) count, 
hematocrit (Ht) and haemoglobin (Hb) concentration were all 
determined by use of an automated blood analyzer (QBC Autoread 
Plus, UK). The blood samples were first pipetted into QBC capillary 
tubes and spurn in a parafuge centrifuge (Becton Dickson, UK) for 5 
min and read by means of an autoread analyzer. 
2.10. Biochemical assays 
   The sera prepared above were used to estimate total cholesterol 
(TC), high-density lipoprotein (HDL) cholesterol, serum triglycerides 
(TG), low-density lipoprotein (LDL) cholesterol, aspartate 
aminotransferase (AST) and alanine aminotransferase (ALT). Total 
cholesterol, HDL cholesterol and triacylglycerol were determined 
by enzymatic methods as described by Roeschlau, et al[20], using 
the kit Hospitex Diagnostics s.r.l. (Italy). The LDL cholesterol was 
calculated using the formula of Friedewald et al.[21]: 
    LDL = TC - HDL - (TG/5)
   The atherosclerosis index (LDL/HDL) was calculated[22]. AST and 
ALT were assayed with the method described by IFCC[23], using 
the kit Hospitex Diagnostics s.r.l. (Italy). Serum creatinine and 
urinary creatinine were quantified by kinetic method of Newman 
and Prince[24], using the kit Hospitex Diagnostics s.r.l. (Italy). Total 
serum protein and organ proteins (liver, lungs, heart and spleen) were 
assayed by the Biuret method[25], while urinary proteins and kidney 
proteins were quantified by the method of Bradford[26]. 
2.11. Measurement of the percentage of weight gain, daily 
feed and water intakes 
   The amounts of feed and water consumed were measured daily 
from the quantity of feed and water supplied and the amount 
remaining after 24 h. The weight increase or weight loss of 
animals was evaluated daily and the percentage of weight gain was 
determined. 
 
2.12. Histopathological analysis 
   Tissue cross sections were prepared and analyzed using 
conventional techniques described by Di Fiore[27]. After sacrificing 
the animals, small pieces of liver were fixed in 10% formalin, 
dehydrated in ascending grades of alcohol and cleared in xylene. 
The fixed tissue were embedded in paraffin wax and sectioned into 
five micrometres thick with the rotary microtome, then stained with 
hematoxylin and eosin. Then the sections were examined with light 
microscope and photographed using a microscopic camera. 
2.13. Statistical analysis 
   Data obtained were expressed as mean ± SEM and were statistically 
analysed using One-way ANOVA. The Waller Duncan test was used 
to compare means of different groups. A P-value of < 0.05 was 
considered statistically significant.
2.14. Ethics
   This work was carried out with respect for the welfare of animals, 
as recommended by WHO[28].
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3. Results
3.1. In vivo antibacterial activity of aqueous extract of E. 
prostrata in rat 
   In general, the number of viable S. typhimurium recovered from 
faeces increased during the first day following the infection. The 
administration of E. prostrata extract was found to induce marked 
decreases on the number of viable S. typhimurium recovered 
from faeces as indicated by Figure 1. Animals (female and male) 
treated with different doses of the extract did not shed any viable 
S. typhimurium in faeces between the eighth and tenth days of 
the treatment period. The same observation was made for those 
treated with standard antibiotics between the fourth and sixth days 
of the treatment period. The number of viable S. typhimurium also 
decreased in the faeces of infected and untreated control animals, but 
this only occurred three to four days after that of the treated animals.
3.2. Effect of the extract on body weight trends, feed and 
water consumption 
   There were generally no significant changes (P > 0.05) in food 
and water consumption patterns (Table 1). However, an increase of 
percentage of weight gain in general for animals of both sexes was 
observed during the 14 days treatment period as shown by Figure 2.
Table 1
Food and water consumption of rats during in vivo studies.
Sex Doses 
(mg/kg)
Food consumption (g) Water consumption (mL)
1st week 2nd week 1st week 2nd week
Female     0 97.67 ± 28.32a 109.14 ± 8.30a   97.21 ± 7.07a   90.60 ± 7.08a
    0i 76.43 ± 35.52b   92.86 ± 24.75b   88.40 ± 3.36a   74.00 ± 1.87c
 26.34  91.43 ± 27.35ab 101.14 ± 23.28ab   94.00 ± 7.25a   87.00 ± 3.70abc
 44.00  91.86 ± 21.74ab 104.29 ± 13.99a   86.80 ± 7.26a   76.40 ± 3.23bc
 73.48 83.71 ± 19.43b 109.57 ± 15.17a 101.40 ± 3.37a   95.60 ± 5.37ab
122.71 96.33 ± 33.41a 109.14 ± 20.61a   96.33 ± 7.26a   94.64 ± 5.31ab
Male      0 98.14 ± 24.77a 116.57 ± 21.65a 121.80 ± 4.96a 106.57 ± 8.04a
     0i 78.86 ± 35.21b   94.71 ± 26.97c   97.40 ± 4.79a   94.20 ± 10.96a
 26.34  92.86 ± 26.96ab 102.14 ± 25.47bc 107.80 ± 5.00a 109.20 ± 6.18a
 44.00  91.86 ± 21.74ab 105.43 ± 15.59b 104.00 ± 2.27a   96.80 ± 5.46a
 73.48  95.14 ± 26.90ab 110.00 ± 15.74ab 103.04 ± 2.25a 106.00 ± 7.30a
122.71  94.29 ± 31.32ab 110.57 ± 20.90ab 113.80 ± 12.47a   98.57 ± 11.52a
Values are mean ± SEM of 5 determinations. Data in the same column in the 
same sex with different superscript letters are significantly different (P < 0.05). 
0: non infected and untreated control group; 0i: infected and untreated group.
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Figure 2. Body weight gain trend for female Wistar rats (A) and male 
Wistar rats (B) fed with aqueous extract of E. prostrata for 14 days. 
0i: infected and untreated rats; 0 mg/kg: non infected and untreated 
rats (  neutral and control). Each data point represents the mean ± 
SEM. (n = 5).
3.3. Effect of the extract on the relative organ weights after 
two weeks of treatment
   The relative organ weights of liver, heart and spleen did not show 
any significant (P > 0.05) differences between the treated groups of 
both sexes and the neutral control groups (non infected and untreated 
groups). Meanwhile, in female rats there was a significant increase 
of the relative organ weight of kidneys at the dose of 122.71 mg/
kg. A significant (P < 0.05) increase of the relative organ weight of 
lungs was observe at the doses of 26.34 mg/kg in female and 73.48 
mg/kg in male (Table 2).
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Figure 1. Effects of treatment with aqueous extract of E. prostrata on fecal shedding of S. typhimurium (CFU/g) by female (A) and male (B) rats.
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Table 2
Effects of aqueous extract of E. prostrata on proteins profiles of liver, 
kidney, heart, spleen and lungs after 14 days of treatment.
Sex Doses 
(mg/
kg)
Proteins levels (mg/g of organs)
Liver Spleen Kidney Heart Lungs
Female     0 39.21 ± 0.49ab  5.25 ± 1.07ab 11.06 ± 0.57c 3.93 ± 0.06a   7.10 ± 0.52b
    0i 36.84 ± 2.10b 4.09 ± 0.42b 11.49 ± 1.11bc 3.65 ± 0.37a   7.79 ± 2.62b
 26.34 43.28 ± 3.99a 6.51 ± 2.55a 12.33 ± 0.63b 4.21 ± 0.19a 11.67 ± 1.75a
 44.00 37.72 ± 2.99ab 3.34 ± 1.59b 10.82 ± 1.25c 4.10 ± 0.26a   8.55 ± 0.58b
 73.48 43.21 ± 7.96a 4.84 ± 0.31ab 11.61 ± 0.27bc 3.97 ± 0.36a   8.55 ± 1.62b
122.71 43.47 ± 2.27a 5.48 ± 1.36ab 13.64 ± 0.82a 4.81 ± 0.87a   8.79 ± 0.56b
Male     0 42.38 ± 6.45a 5.23 ± 0.92a 10.99 ± 1.15ab 3.82 ± 0.56a   7.17 ± 1.64b
    0i 34.91 ± 6.05b 5.06 ± 0.93a 13.50 ± 3.28a 4.13 ± 0.64a 10.92 ± 1.77a
 26.34 36.69 ± 3.78ab 4.73 ± 0.94a 10.43 ± 0.58b 4.23 ± 0.13a   6.80 ± 0.68b
 44.00 38.45 ± 1.63ab 4.12 ± 0.72a 10.66 ± 1.39ab 3.7 ± 0.14a   8.19 ± 0.67b
 73.48 40.84 ± 2.30ab 5.02 ± 0.43a 12.05 ± 1.10ab 4.02 ± 0.18a   9.98 ± 1.16a
122.71 39.75 ± 1.22ab 4.74 ± 0.52a 13.23 ± 2.47ab 3.76 ± 0.11a   7.17 ± 0.80b
Values are mean ± SEM of 5 determinations. Data in the same column in the 
same sex with different superscript letters are significantly different (P < 0.05). 
0: uninfected and untreated control group; 0i: infected and untreated group.
3.4. Effect of aqueous extract of E. prostrata on the 
haematological parameters of rats
   The hematological analysis (Table 3) showed no significant (P 
> 0.05) changes in the RBC and WBC of rats (female and male), 
while there was a significant (P < 0.05) increase of Hb in females 
compared to the neutral control group. Also, there was a significant 
(P < 0.05) increase of Ht in males at the dose of 122.71 mg/kg, and 
no significant changes in female.
Table 3
Haematological parameters following 14-day treatment of rats with 
aqueous extract of E. prostrata.
Sex Doses 
(mg/kg)
RBC 
(伊106/mm3) 
  WBC 
(伊106/mm3)
Hb
(g/dL) 
Ht
(%)
Female      0 6.2600 ± 0.9100a   5.80 ± 0.84b 12.00 ± 1.87b 36.20 ± 1.92a
     0i 2.6225 ± 1.1100c 10.53 ± 1.30a 16.05 ± 0.90a 33.50 ± 2.36a
 26.34 5.4600 ± 0.5400ab   6.85 ± 0.60b 15.15 ± 1.70a 36.30 ± 7.95a
 44.00 6.1000 ± 0.4100ab   6.85 ± 2.41b 15.05 ± 1.21a 33.35 ± 2.36a
 73.48 4.6800 ± 0.5060b   5.08 ± 3.31b  13.93 ± 1.88ab 33.35 ± 1.85a
122.71 4.6300 ± 1.3800a   6.10 ± 0.84b 14.02 ± 1.86a 35.50 ± 4.20a
Male      0 6.2500 ± 0.9600a    5.75 ± 1.26bc 13.75 ± 1.50a  35.00 ± 2.16bc
     0i 4.8900 ± 0.9300a   9.42 ± 2.71a 15.28 ± 2.61a 29.28 ± 4.25c
 26.34 5.0000 ± 0.7070a    5.70 ± 1.20bc 15.00 ± 1.58a  38.20 ± 5.59ab
 44.00 5.9900 ± 0.6000a   4.04 ± 0.95c 13.40 ± 1.43a  34.40 ± 5.27bc
 73.48 5.8200 ± 1.3100a    8.28 ± 4.03ab 15.14 ± 1.59a  39.08 ± 9.07ab
122.71 5.7500 ± 0.4400a   5.00 ± 1.58c 15.28 ± 2.61a 42.86 ± 2.35a
Values are mean ± SEM of 5 determinations. Data in the same column in the 
same sex with different superscript letters are significantly different (P < 0.05). 
0: uninfected and untreated control group; 0i: infected and untreated group.
3.5. Effect of aqueous extract of E. prostrata on serum and 
urinary creatinine, serum and urinary proteins of rats
   In general, no significant difference in serum and urinary creatinine 
level were observed in animals of both sexes (treated with different 
doses), compared to the neutral controls (non infected and untreated 
group). However, the extract caused a significant decrease of serum 
proteins at doses greater than or equal to 44 mg/kg in females, and a 
significant increase of urinary proteins in the infected and untreated 
male group, compared to the neutral control group (Table 4). There 
were no significant differences in urinary proteins between the 
infected and untreated group and the treated male groups at all doses.
Table 4 
Effects of aqueous extract of E. prostrata on serum creatinine, urinary creatinine, 
serum proteins and urinary proteins of rats after 14 days of treatment.
Sex Dose 
(mg/kg)
Serum creatinine 
(mg/dL)
Urinary creatinine 
(mg/dL)
Serum proteins 
(mg/mL)
Urinary proteins 
(mg/mL)
Female     0 0.35 ± 0.16a  0.85 ± 0.14b 104.40 ± 6.69b  0.34 ± 0.07bc
    0i 0.35 ± 0.22a 1.45 ± 0.33a 115.09 ± 14.64ab  0.35 ± 0.55bc
 26.34 0.40 ± 0.14a 1.00 ± 0.25b 123.18 ± 21.40a  0.38 ± 0.16bc
 44.00 0.35 ± 0.22a  1.05 ± 0.33ab   63.64 ± 9.30cd 0.54 ± 0.06a
 73.48 0.35 ± 0.14a 0.90 ± 0.22b   76.45 ± 17.86c 0.30 ± 0.04c
122.71 0.40 ± 0.14a 1.00 ± 0.35b   53.63 ± 7.01d  0.45 ± 0.06ab
Male      0 0.30 ± 0.11a 0.95 ± 0.21b   80.92 ± 3.00abc 0.37 ± 0.08b
     0i 0.50 ± 0.25a 1.60 ± 0.45a 103.55 ± 12.01a 0.51 ± 0.05a
 26.34 0.35 ± 0.14a  1.25 ± 0.31ab   89.09 ± 38.71ab  0.41 ± 0.02ab
 44.00 0.45 ± 0.33a 1.60 ± 0.80a   46.46 ± 7.43d  0.48 ± 0.05ab
 73.48 0.30 ± 0.11a  1.05 ± 0.11ab   61.54 ± 34.79bcd 0.52 ± 0.05a
122.71 0.30 ± 0.11a 0.95 ± 0.21b   53.55 ± 6.37cd 0.52 ± 0.15a
Values are mean ± SEM of 5 determinations. Data in the same column in the 
same sex with different superscript letters are significantly different (P < 0.05). 
0: uninfected and untreated control group; 0i: infected and untreated group.
3.6. Effect of aqueous extract of E. prostrata on serum TC, 
HDL
 cholesterol, TG and index of atherosclerosis
  
   The results of effect of aqueous extract of E. prostrata on the 
lipid profile after 14 days of treatment are summarized in Table 5. It 
appears from this table that the TG and the index of atherosclerosis 
showed non-significant changes in all treated animals (male and 
female, regardless of dose) compared to neutral control groups. The 
HDL cholesterol and TC showed significant (P < 0.05) decreases in 
treated females. In treated males, the TC and HDL cholesterol did 
not show any significant (P > 0.05) change compared to the neutral 
control. The LDL cholesterol showed significant (P < 0.05) decreases 
in females treated at doses of 26.34 and 73.48 and in male at dose of 
26.34. The TC showed a significant (P < 0.05) decrease in infected 
and untreated male group.
Table 5
Effects of aqueous extract of E. prostrata on some lipid profiles after 14 days 
of treatment.
Sex Dose 
(mg/kg)
TC (mg/dL) HDL cholesterol 
(mg/dL)
LDL cholesterol 
(mg/dL)
TG (mg/dL) Index of 
atherosclerosis
Female     0 124.40 ± 8.35a 45.60 ± 5.90a 62.200 ± 1.818a 81.00 ± 3.16a 1.750 ± 0.300a
    0i   82.00 ± 5.43c 32.60 ± 4.03c 35.400 ± 0.722c 70.00 ± 3.39b 1.540 ± 0.340a
 26.34   88.40 ± 12.05c 33.00 ± 7.25c 39.760 ± 4.284bc 78.20 ± 2.58a 1.730 ± 0.310a
 44.00 108.80 ± 6.05b  37.40 ± 5.45bc 55.600 ± 0.154a 79.00 ± 2.23a 1.970 ± 0.580a
 73.48 101.60 ± 8.96b 40.40 ± 3.13b 45.280 ± 5.602b 79.60 ± 1.14a 1.530 ± 0.350a
122.71 101.80 ± 8.90b  38.20 ± 1.78bc 47.200 ± 6.328b 80.20 ± 3.96a 1.680 ± 0.360a
Male     0 101.40 ± 4.39ab 35.80 ± 4.21a 50.360 ± 0.532a 76.20 ± 356a 1.870 ± 0.390a
    0i   72.60 ± 2.88c 33.20 ± 2.28a 26.080 ± 0.186c 66.60 ± 2.07b 1.190 ± 0.140c
 26.34   93.40 ± 9.63b 37.60 ± 4.04a 40.320 ± 4.918b 77.40 ± 3.36a 1.490 ± 0.230bc
 44.00 105.20 ± 6.98a 36.60 ± 5.68a 53.120 ± 0.406a 77.40 ± 8.53a 1.910 ± 0.313a
 73.48 102.60 ± 9.29ab 36.20 ± 2.86a 50.200 ± 6.110a 81.00 ± 1.58a 1.840 ± 0.180a
122.71   98.60 ± 11.15ab 36.20 ± 3.96a 46.040 ± 6.370ab 81.80 ± 4.09a 1.730 ± 0.140a
Values are mean ± SEM of 5 determinations. Data in the same column in the 
same sex with different superscript letters are significantly different (P < 0.05). 
0: uninfected and untreated control group; 0i: infected and untreated group.
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3.7. Effect of aqueous extract of E. prostrata on serum 
transaminases
   Table 6 summarizes the results of effect of aqueous extract of E. 
prostrata on serum transaminases (ALT and AST) after 14 days of 
treatment. AST activity was significantly elevated in infected and 
untreated control group and at doses greater than or equal to 44 
mg/kg, as compared to uninfected and untreated control group, for 
females and males. Also, ALT activity was significantly increased 
at doses of 26.34, 44.00 and 73.48 mg/kg for females and at doses 
greater than or equal to 44.00 mg/kg for males.
Table 6
Transaminases (ALT and AST) levels in serum samples from animals treated 
with aqueous extract of E. prostrata.
Sex Dose (mg/kg) ALT (IU/L) AST (IU/L)
Female            0 28.07 ± 2.98b 60.51 ± 4.68d
           0i 37.80 ± 3.42a  83.60 ± 3.05bc
 26.34 45.40 ± 5.77a  76.80 ± 2.86cd
 44.00   45.40 ± 10.16a    96.40 ± 18.38ab
 73.48 44.60 ± 6.54a 102.40 ± 12.79a
122.71 37.75 ± 4.60b     95.00 ± 23.10ab
Male            0 35.68 ± 3.56c  82.40 ± 5.03b
           0i  40.20 ± 4.21bc  91.00 ± 4.64b
 26.34  38.00 ± 7.75bc    88.80 ± 21.58b
 44.00  46.27 ± 5.32ab  114.40 ± 20.22a
 73.48   55.00 ± 11.34a  121.20 ± 21.29a
122.71 51.00 ± 8.71a  124.00 ± 10.32a
Values are mean ± SEM of 5 determinations. Data in the same column in the 
same sex with different superscript letters are significantly different (P < 0.05). 
0: uninfected and untreated control group; 0i: infected and untreated group.
3.8. Effect of aqueous extract of E. prostrata on the histology 
of the liver sections
   Histology of the liver sections (Figure 3) of uninfected and 
untreated control animals (neutral control), and of those infected 
and treated at doses ≤ 44 mg/kg showed normal hepatic cells with 
well-preserved cytoplasm, prominent nucleus and visible central 
veins. The liver sections of infected and untreated control rats 
showed dilation of sinusoid, inflammation of the parenchyma and 
the portal space. At doses ≤ 44 mg/kg liver cross sections showed 
a normal appearance, similar to that of neutral control group. The 
histological architecture of liver sections of the animals treated 
with doses ≥ 73.48 mg/kg (females) and ≥ 122.71 mg/kg (males) 
of aqueous extract of E. prostrata showed injury pattern like 
significant inflammation of the parenchyma and the portal space, 
and vascular congestion.
4. Discussion
4.1. In vivo assay
   Based on information provided by both the traditional healer and 
the in vitro antibacterial test results, in vivo study was undertaken 
in a view to verifying the therapeutic efficacy of the extract. Results 
of present research showed that the administration of aqueous 
extract of E. prostrata inhibited the growth of S. typhimurium, and 
thus reduced the numbers of viable S. typhimurium recovered from 
faeces. This reduction was dose dependent in animals infected and 
treated in both sexes, and their bacterial load was cancelled out 
within 8 to 10 days of treatment. All of these observations suggested 
that antimicrobial activity against S. typhimurium observed in vitro 
was maintained in vivo. The marked decrease of the bacterial load 
in infected animals after the start of the treatment could be due to 
the combined actions of the extract and the immune system, since 
a decrease was also observed in the negative controls (infected and 
untreated). However, this only occurred in the negative controls 
three to four days after that of the treated animals. This reduction 
of bacterial load in the negative controls could be explained by the 
regeneration of the immune system, since the latter was weakened 
to let the infection occur.
   The use of E. prostrata in traditional medicine[29,30] could partly 
be justified by the above findings, and we believe that this plant 
extract could be a potential novel antimicrobial for the treatment 
of salmonellosis, including typhoid fever. Several metabolites 
from plant species, including alkaloids, tannins and sterols, have 
Figure 3. Histopathological changes in liver of infected rats after 14 days of treatment (400伊). A: Intact lobular architecture and normal hepatocytes of 
infected and untreated rats; B: Dilation of sinusoid, inflammation of the parenchyma and the portal space, and cell degenerescence were observed within the 
liver of infected and untreated rats; Hepatocytes with well-preserved nuclear to cytoplasmic ratio and very slight inflammation in groups F3 (C), M3 (D), F4 
(E), M4 (F), M5 (H); Focal inflammatory cells infiltration (i.e. more injury pattern) in groups F5 (G) and F6 (I); J: Slightly inflammatory cells infiltration and 
vascular congestion in group M6.
A B C D E
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previously been associated with antimicrobial activity[31,32]. The 
detection of these classes of secondary metabolites in the extract[16] 
could explain the observed activities.
   The protein must be eliminated in very small quantities in urine. 
Therefore, an increase in their removal is a sign of glomerular 
damage[33]. The extract appears to significantly increase the 
concentration of urinary protein in females treated at dose of 44.00 
mg/kg, and in males at doses greater or equal to 73.48 mg/kg. This 
increased rate of urinary protein may indicate a renal toxicity that 
the extract could induce in these animals. Meanwhile, the significant 
increase observed in female between non infected and untreated, 
and infected and untreated may be attributed to the infection.
4.2. Hematological study
   The hematological status after 14 days of oral administration of 
aqueous extract of E. prostrata was also assessed. In general the 
results showed that the values for the RBC, WBC, Hb and Ht were 
not significantly different as compared to the neutral control groups 
and fell within the normal range. The anaemia observed in infected 
and untreated female control as indicated by the RBC count could 
possibly be attributed to the various pathophysiological effects 
produced during Salmonella infection in rodent. Proliferation of 
Salmonella in rodents, controlled by a gene Nramp[34], could lead 
to chronic cell lysis due to the presence of free radicals produced 
during inflammatory reactions[35]. It has been established that 
the degree of anaemia always correlates well with increase in 
parasitemia[36].
4.3. Lipid profile
   Numerous studies have pointed out the increased risk of coronary 
disorders with elevated levels of TC, TG, and LDL-cholesterol[37]. 
In a study on apparently healthy women, it has been observed 
that levels of TC, LDL-cholesterol, and the ratio of TC to HDL-
cholesterol were significantly associated with increased risk of 
ischemic stroke[38]. High level of serum TC and LDL-cholesterol 
have been shown to pose a significant risk in ischemic stroke, 
whereas high levels of HDL-cholesterol indicated beneficial effects 
on the atherosclerotic process[39]. A high LDL/HDL ratio has also 
been reported to have a high predictive value of a first coronary 
event[22]. In the present study, it was observed that administration 
of aqueous extract of E. prostrata to rats did not induce significant 
changes in the serum levels of TC, TG, and HDL-cholesterol 
in male, while the levels of TC and HDL-cholesterol decrease 
significantly in female. Beside, no significant increase of LDL 
cholesterol and atherosclerosis index were observed in animals of 
both sex. This result suggests that E. prostrata contains component 
which may have no risk of cardiovascular and coronary diseases.
4.4. Transaminase and microscopic examination
   Transaminases are enzymes that catalyze the transfer of an 
amino group from an amino acid to an α-keto acid. The increase in 
transaminase levels in the blood is indeed indicative of a number 
of ailments[40]. The AST and ALT are enzymes commonly used as 
markers of hepatic necrosis[41-43]. ALT is localized primarily in 
hepatocytes, whereas AST is found in most tissues including the 
heart, kidneys and liver[44]. In case of hepatotoxicity, ALT and AST 
increase simultaneously in serum, but the ALT increase persists 
longer than the AST[45]. In this study, AST was significantly elevated 
in infected and untreated control group and at doses greater than 
or equal to 44.00 mg/kg, as compared to uninfected and untreated 
control group, for females and males. Also, ALT activity was 
significantly increased at doses of 26.34, 44.00 and 73.48 mg/kg for 
females and at doses greater than or equal to 44 mg/kg for males, 
suggesting hepatic damage. The elevation of these parameters 
in infected and untreated control is due to the infection. In fact 
during typhoid fever, there is an increase of serum transaminase 
activity[46,47], which reflects liver damage, due to the accumulation 
of bacteria at this level[48]. 
   The attribution of the increase in serum ALT and AST enzymes to 
liver damage was further strengthened by microscopic examination 
of liver sections. Histology of the liver sections of uninfected and 
untreated control animals (neutral control), and of those infected 
and treated at doses of 44 mg/kg showed normal hepatic cells 
with well-preserved cytoplasm, prominent nucleus and visible 
central veins. The liver sections of infected and untreated control 
rats showed dilation of sinusoid, inflammation of the parenchyma 
and the portal space that may be attributed to infection. The same 
observation was made by Choi et al.[49] on the liver of mice 
infected with S. typhimurium and untreated. At doses of 44.00 mg/
kg liver cross sections showed a normal appearance, similar to 
that of neutral control group. Therefore, the extract at these doses 
would not only treat the infection, but might have corrected liver 
cell damage caused by the infection. The histological architecture 
of liver sections of the animals treated with doses of 73.48 mg/
kg (females) and ≥122.71 mg/kg (male) of aqueous extract of E. 
prostrata showed injury pattern like significant inflammation of 
the parenchyma and the portal space, and vascular congestion. This 
may be explained by the fact that at relatively high doses, the extract 
had the ability to induce liver damage. However, the apoptosis or 
necrosis of hepatocytes remains one of the major signs of liver 
damage due to toxic compounds[50], and this was not observed in 
this study.
   The overall results of the present work provide baseline 
information for the possible use of the aqueous extract of E. 
prostrata in the treatment of salmonellosis, especially typhoid 
fever. In addition to antibacterial activity, the data reported from 
acute toxicity showed that the extract may be non toxic. These 
observations can justify the traditional use of the plant in the 
treatment of typhoid fever. Moreover, the in vivo antibacterial 
activity revealed that the dose of extract obtained from (or used 
by the) traditional healer may be considered as relatively safe, as 
shown by the results of subacute toxicity evaluation. However, the 
extract may induce slight liver damage at high doses. Subchronic 
and chronic toxicity studies are necessary to further support the safe 
use of this plant. It is also necessary to extrapolate these results in 
large animals.
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Comments 
Background
   Typhoid fever is an important global health problem in Africa 
where sanitary conditions are inadequate and access to clean 
water is limited. Since the use of conventional antibiotics is costly, 
there has been considerable interest in the use of plants as an 
alternative method to control the disease. This study showed that 
extract of E. prostrata Aiton could stop salmonellosis after 8-10 
days of treatment of infected rats, with non toxic doses. However, 
the hematological, biochemical and histopathological analyses 
indicated that at higher doses, the extract could induce liver and 
kidney damage. This study showed that E. prostrata can be used for 
the treatment of typhoid fever with satisfactory efficacy and safety. 
  
Research frontiers
   The present study shows that extract of E. prostrata Aiton could 
stop typhoid fever at normal doses after 8 to 10 days and evaluated 
the hematological, biochemical and histopathological side effect of 
the use of relatively higher doses.
Related reports
   Various parts (i.e., flowers, leaves, barks and roots) of Cassia 
petersiana were selected and tested against S. typhi, S. paratyphi 
A and S. paratyphi B. This was with a view to ascertaining and 
assessing their traditionally claimed antityphoid properties.
Innovations and breakthroughs
   It has been reported that E. prostrata Aiton can be used for the 
treatment of grade I and II of hemorrhoids with satisfactory efficacy 
and safety (Gupta, 2011). In this work authors have demonstrated 
that the aqueous extract of this plant can be used in the treatment of 
typhoid fever.
Applications
   This study gave the scientific basis of the use of E. prostrata Aiton.
Peer review
   In the present study, it was observed that the aqueous extract of 
E. prostrata Aiton can be used in the treatment of typhoid fever 
with satisfactory efficacy and safety. However, hematological, 
biochemical and histopathological analyses indicated that, at 
relatively higher doses, the liver and kidney could be damaged. 
Information generated in this study could be the reference for the 
routine use of aqueous extract of the aforementioned plant in the 
treatment of typhoid fever after extrapolation in human being. 
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